News from embl ventures A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

13 Sep, 2018, 07:00 BST EMBL Ventures Portfolio Company, ViraTherapeutics, Acquired by Boehringer Ingelheim in EUR 210 Million (USD 245 Million) Transaction

ViraTherapeutics sale marks third exit from EMBL Ventures' current fund ETF II EMBL Ventures, a leading early stage European life science venture...


13 Sep, 2018, 07:00 BST EMBL Ventures Portfolio Company, ViraTherapeutics Acquired by Boehringer Ingelheim in EUR 210 Million (USD 245 Million) Transaction

ViraTherapeutics sale marks third exit from EMBL Ventures' current fund ETF II EMBL Ventures, a leading early stage European life science venture...


14 Oct, 2015, 07:00 BST EMBL Ventures Co-leads Luxendo Series A Financing Round

Luxendo, a start-up company launched by the European Molecular Biology Laboratory (EMBL) and its technology transfer arm EMBLEM Technology Transfer...